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AUSTRAGT: DCs are known foc their supenor antigen-
processing and antigen-presenting capacities They are
capable of processing incact protein either endocytosed
exogenous proteins or newly synthesized endogenous viral
and bactenal proteins They are potent inducers of pn-
mary T-cell immune responses such as in allogeneic
MLRs It IS also known that DCs can provide a strong
Stimulus for autologous T-cell proliferation So far no
Information exists on the capacity of DCs to induce pri-
mary mH antigen-specific T-cell responses Therefore, we
investigated whether human DCs, isolated from periph-
eral blood, were able to generate specific T-cell responses
between MLR-negative HLA genotypically identical ιη-
dividuals m vitro To this end, unfractionated cells,
monocytes, and Β cells were assayed in parallel with DCs
to compare their capacity to activate unpnmed Τ cells in
a primary MLR DCs indeed mduced significant prohf-
eration between HLA genotypically identical siblings,
whereas the other APCs were unable to evoke any T-cell
response at all As expected, besides these allogeneic
T-cell responses, autologous T-cell responses were initi-
ated by the DCs as well Nonetheless, despite further
detailed analyses of the responding Τ cells, neither pro-
liferative nor cytotoxic mH antigen-specifk reactivities
could yet be detected using the Stimulation protocols de-
scnbed herein Human Immunology 44, 181-188 {1995)
ABBREVIATIONS
APC antigen-presenting cell mAb
BMT bone marrow transplantanon mH
DC dendmic cell MHC
EBV-LCL Epstein-Barr virus-transformed B-cell MLDCR
hne MLR
ER erythrocyte rosette NK
GAM goat-anti-mouse PBMC
GvHD graft-versus-host disease PLT
monoclonal antibody
minor histocompanbility
major histocornpatibility complex
mixed leukocyte DC reaction
mixed leukocyte reaction
natural killer
penpheral blood mononudear cell
pnmed lymphocyte test
INTRODUCTION
Despite advances in bone marrow Transplantation (BMT)
conditioning, better graft-versus-host disease (GvHD)
prophylaxis, and HLA matchmg, the occurrence of
GvHD is still a major drawback in allogeneic BMT. In
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HLA genotypically identical combinations, differences
for minor histocompatibihty (mH) antigens between BM
donor and recipient can play a role in the development of
GvHD [1] These mH antigen differences cannot be
identified in a primary mixed leukocyte reaction (MLR)
In vivo pnming prior to in vitro sensmzation is generally
required to ehcit T-cell responses in vitro against such
disparities In this study, we focused on the use of a more
adequate antigen-presenting cell (APC) as sumulator cell
to attempt to induce primary mH antigen-specific T-cell
responses in vitro
Previous studies have identified human dendntic cells
(DCs) as a small fraction (<1%) of penpheral blood
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mononuclear cells (PBMCs) [2, 3]. Human blood DCs
share the distinctive features of their counterparts in
other species such as cell shape and abundant expression
of major histocompatibility complex (MHC) class I and
II products [4-8], although they cannot yet be identified
by specific cell markers in the same manner as, for ex-
ample, 33D1 and murine DCs [9]. DCs are the most
potent inducers of both alloreactive and autoreactive Τ
cells [3> 10]; furthermore, they are very efficient in
priming resting Τ cells in vitro. Moreover, it has been
shown that DCs pulsed with protein antigen are capable
of priming antigen-specific MHC-restricted Τ cells both
in vivo and in vitro [11—14].
Based on this knowledge, we performed a series of
mixed lymphocyte DC reactions (MLDCRs) using DC as
stimulators, to ascertain whether mH antigen differences
between healthy HLA genotypically identical, MLR-
negative sibling pairs could be demonstrated. The re-
sponding Τ cells, both cytotoxic and proliferative, were
analyzed in detail for their antigen-specific reactivities.
MATERIALS AND METHODS
Human subjects. Buffy coats from 0.5 1 of blood were
obtained from 13 healthy HLA genotypically identical
sibling pairs and two twin pairs. HLA typing was per-
formed by serology for HLA-A, -B, -C, -DR, and -DQ
and by oligonucleotide typing for HLA-DP. All of the
pairs used in this study were fully HLA identical and
nonproliferative in a Standard MLR.
Isolation of DC: cell Separation. Enrichment of DC was
performed according to the method described by
Freudenthal and Steinman [9} with minor modifications.
In short, PBMCs were separated into T-cell-enriched
(erythrocyte rosette-positive [ER + ]) and T-cell-depleted
(ER") fractions by rosetting with AET-treated sheep red
blood cells. Τ cells were recovered from ER + fractions
by lysing the erythrocytes in NH4C1, yielding >95%
CD3 + Τ cells. The T-cell-depleted fraction was cultured
for 36 hours in tissue culture dishes. By reculturing the
dislodged cells twice, monocytes selectively attached to
the plastic culture dishes. The adherent monocytes could
be collected by firm scraping. Nonadherent cells were
layered onto 14.5% metrizamide to separate Β and nat-
ural killer (NK) cells from the DCs. Residual monocytes
or Β cells in the low-density fraction could be depleted
by using magnetic beads (Dynal, Norway) which had a
primary coat of goat—anti-mouse (GAM) IgG and a sec-
ondary coat of anti-CDl4 or anti-CD19 mouse IgG.
The monocyte, B/NK cell, and DC fractions derived
from the cell Separation, as just described, were analyzed
on a FACScan (Becton-Dickinson) for purity and MHC
class II expression by staining with mouse monoclonal
antibody (mAb) either directly labeled or indirectly la-
beled with fluorescein-conjugated GAM antibodies (Bec-
ton-Dickinson). Expression of high levels of MHC II
(DR, DP, and DQ) molecules, in addition to the absence
of lineage-specific markers, is a distinctive feature of DCs
[6-9]· mAb directed at the latter molecules were there-
fore used to identify DCs and to distinguish them from
residual monocytes and Β cells in the purified fraction.
To confirm the FACS analyses, in some cases cytospin
preparations of the DC-enriched fractions were stained
for acid phosphatase and MHC class II, and/or electron
microscopy of these fractions was performed.
T-cell proliferation assay; MLDCR. From 13 HLA geno-
typically identical MLR-negative sibling pairs and two
twin pairs, primary proliferation assays were performed.
Each cell type, i.e., monocytes, Β cell, NK cells, and
DCs, isolated as just described, was tested simulta-
neously in the same experiment for its stimulatory capac-
ity. As responder cells, both Τ cells and unseparated
PBMCs were assayed. All MLDCRs were carried out as
follows. Threefold serial dilutions (1.5 Χ 104 to 50
cells/well) of irradiated (3000 rad) stimulator cells were
added in quintuplicate to 5 Χ 104 responder cells in
96-well round-bottom plates. After 5 days of culture, 1
μΟΛνεΙΙ [3H]thymidine was added to the MLDCR for
the last 16-18 hours.
Generation of T-cell lines. DC-induced T-cell responses of
eight of the 13 HLA genotypically identical MLR-
negative sibling pairs were further analyzed. T-cell re-
sponses were initiated either with a CD4-depleted T-cell
population or with purified nondepleted Τ cells, and
stimulated with DCs. T-cell lines were established either
by weekly Stimulation with PBMCs and Epstein-Barr
virus-transformed B-cell lines (EBV-LCLs) of the specific
stimulator in the presence of 1% leuco-A and 20 U/ml
rIL-2 (designated as "Standard protocol"), or by adding a
Single dose of rIL-7 (60 ng/ml) 36 hours after the initi-
ation of the culture (designated as "rIL-7 protocol"). In
the latter protocol, T-cell lines could be cultured and
expanded for 3 weeks without the addition of other cy-
tokines or specific stimulator cells. All T-cell lines were
analyzed weekly on a FACScan for their CD3, CD4, and
CD8 expression.
Primed lymphocyte lest (PLT). To assay the secondary pro-
liferative response, the T-cell lines were repeatedly tested
in PLT. Responder Τ cells, 104, were added to either 105
PBMCs (3000 rad irradiated) or 0.25 Χ 105 EBV-LCL
(8000 rad irradiated) in 96-well flat-bottom plates.
These were performed in triplicate. Proliferation was ex-
pressed in Stimulation indices (SI):
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FIGURE 1 All enriched fractions were analyzed on a
FACScan for purity. To estimate the percentage of DCs in the
DC-enriched fraction, the high expression of MHC class II
molecules was used as a distinctive feature, besides the absence
of CD3, CD14, CD19, CD16, and CD56. Α high expression
of HLA-DP and HLA-DQ was shown on a population of cells
in the DC-entiched fraction but was absent on the other iso-
lated fractions; i.e., monocytes (>95% CD14+) and B/NK
cells (consists of 60% of Β cells and 20% of NK cells).
SI =
cpm experimental combination
cpm responders alone +
cpm stimulators alone
Cytotoxicicity assay. Cytotoxicity of the T-cell lines was
assayed repeatedly in a Standard chromium-release assay
[15} at different effector-target cell ratios. Phytohemag-
glutinin-stimulated PBMCs (i.e., PH Α blasts) or EBV-
LCLs were used as targer cells and added in duplicate to
the effector Τ cells. Percentages of speciflc 5 1Cr release
were calculated as follows:
lysis =
experimental release —
spontaneous release
maximal release —
spontaneous release
X 100%
Cell culture medium. RPMI 1640 (Gibco) was supple-
mented with antibiotics (100 IU/ml penicillin and 100
μg/ml streptomycin) and L-glutamine (3 mM) and 10%
human serum.
RESULTS
DC Isolation. DCs were enriched from buffy coats of
healthy blood donors. As analyzed on a FACScan, all DC
preparations contained >50% DCs. Figure 1 shows DC
expressing high levels of MHC class II products. These
high MHC class II expressing cells were found to be
negative for the markers CD3, CD 14, CD 19, CD16,
and CD56 in double staining tests (data not shown). The
FACScan analyses were confirmed by electronmicroscopy
(Fig. 2A) and by cytospin preparations, stained for MHC
II and acid phosphatase (as shown in Fig. 2B). In both
tests the majority of cells in the enriched fraction could
be identified as DCs. Cells contaminating the DC frac-
tions were mostly NK cells and less than 10% residual
monocytes.
DCs induce primary MLRs between HLA-identkal sib-
lings. The capacity of DCs to induce primary T-cell re-
sponses was analyzed in 13 HLA genotypically identical
sibling pairs and two twin pairs. All combinations were
negative in a Standard MLR. The superior sdmulatory
capacity of DCs was clearly shown by simultaneously com-
paring monocytes and Β cells as stimulator cells in a
primary proliferation assay (Fig. 3)· Even at the highest
concentration of stimulator cells per well, monocytes, Β
cells, or unfractionated PBLs were not able to yield a
response comparable to DCs. Of the thirteen HLA ge-
notypically identical sibling pairs, 10 displayed a posi-
tive MLDCR. In three of the 13 HLA-identical sibling
pairs the MLDCR was negative (data not shown). The
primary T-cell responses of five of the 10 MLDCR-
positive sibling pairs and of one of the two twin pairs
(pair no. 9405) are depicted in Fig. 4. Although in the
five sibling combinations shown in Fig. 4 a significant
MLDCR is demonstrated, it is clear that a variability in
responsiveness both within and between the HLA iden-
tical pairs is also observed. None of the twin pairs dem-
onstrated a proliferative T-cell response. The results from
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FIGURE 2 Electron micro-
scopic analysis of the DC-
ennched fraction confirmed the
charactenstic morphology of
DCs (A). Cytospin preparations
provided an extra help in the
Identification of DCs DCs show
a distinctive morphology and
have a cluster of acid-phos-
phatase-nch endosomes near the
nucleus <B)
a representacive twin pair (pair no 9405) are shown in
Fig 4. Both positive and negative responses were found
to be reproducible
In some combinations the DC induced high autolo-
gous responses This property IS inherent to the potent
APC function of the DC and was noted earher by other
investigators [3] Nonetheless, lt interfered with the In-
terpretation of the results of the MLDCR (Fig 4 pair
no 9557 Β Χ Β and pair no 9379 Α Χ Α) In an
attempt to avoid these autologous responses, the DC
Isolation and the MLDCR test were performed in autol-
ogous plasma instead of alloserum, however, this did not
eliminate the autologous responses (data not shown).
Analyst! of DC-tnduced T-cell responses To analyze the
specificity of the DC-induced T-ceII responses, T-cell
hnes were generated from eight HLA genotypically lden-
tical sibhng combinations in which the MLDCR was
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FIGURE 3 The stimulatory capacities of different APCs
(DCs, monocytes, B/NK cells, and unsepatated PBMCs) were
compared in a primary proliferation assay. Concentrations of
1.5 X 104 to 50 stimulator cells/well were used to stimulate
5 X 104 responder Τ cells. The response of individual Α
against ehe different APCs from individual Β from pair no.
9384, which is representative for the other sibling combina-
tions, is depicted. Symbols give mean ± Standard error of the
mean (SEM; η — 5). The error bars were omitted when they feil
within the Symbol.
found to be positive. T-cell responses were initiated with
either a CD4-depleted T-cell population or nondepleted
purified Τ cells and stimulated with DCs. Responding Τ
cells were further expanded using either the Standard
protoeol or the rIL-7 protoeol (see Material and Methods).
The T-cell lines induced by DC were functionally ana-
lyzed for cytotoxicity in a CML assay and for proliferative
activity in a PLT assay at least twice. CD4/CD8 pheno-
type of the T-cell lines (all CD3 positive) was analyzed on
a FACScan. The results are summarized in Table 1. Au-
tologously induced T-cell lines (i.e., Α Χ Α or Β Χ Β)
are not depicted in Table 1, as most of these lines were
difficult to expand and did not exhibit any functional
activity. Analysis of the phenotype of the DC-induced
T-cell lines revealed an overgrowth of the CD4 pheno-
type in aJi cases where the responder cell population was
not depieted for CD4. This overgrowth of the CD4 phe-
notypic Τ cells was more pronounced when the Standard
protoeol was used for expansion of the T-cell lines. T-cell
lines of mainly CD8 phenotype could therefore only be
established when the responding T-ceü population was
depieted for CD4 prior to the initiation of the response
with DCs. The CD8-positive Τ cells were most effi-
ciently expanded by using the rIL-7 protoeol.
As outlined earlier, all T-cell lines were assayed for
their functional activity at least twice. In Table 1, pro-
liferative and cytotoxic activity of the T-cell lines be-
tween 2 and 3 weeks of eulture are depicted. Functional
analyses revealed no cytotoxic activity of the DC-induced
T-cell lines generated with nondepleted purified Τ cells,
independent of the eulture protoeol used for expansion.
Cytotoxic activity was observed in the T-cell lines in-
duced with CD4-depleted Τ cells; these latter activities,
however, were equally strong both to the autologous and
speeifie target cells. DC-induced proliferative activity
could be observed in both the CD4-depleted and non-
depleted T-cell lines. Similar to the cytotoxic responses,
the proliferative activities were directed against autolo-
gous and speeifie stimulator cells. The T-cell line from
pair no. 9607-2 displayed, besides a weak cytotoxic re-
sponse, a strong proliferative activity.
It is clear from these results that both the proliferative
and the cytotoxic T-cell lines react to the same extent
with autologous cells and cells of the HLA-identical sib-
ling to which the response was induced. Because the
functional activity of the T-cell lines reflects a summa-
tion of T-cell clones with various speeificities, we per-
formed analysis at the clonal level aimed at separating
Potential mH antigen-speeifie T-cell clones from autore-
active T-cell clones. Analysis of the clones obtained from
0.3 cell/well (N - 63) and from 1 cell/well (N = 73)
from a T-cell line (pair no. 9384-2 Β Χ Α) showed that
these clones exhibited the same functional activity as the
T-cell line, i.e., reactive against both the autologous and
speeifie stimulator cells (data not shown).
DISCUSSION
mH antigen differences between HLA-identical siblings
can form transplantation barriers m allogeneic BMT [ l ] .
In previous studies we observed a significant correlation
between post-BMT anti-host proliferative mH antigen-
speeifie T-cell responses and acute GvHD [16]. T-cell
responses evoked by mH antigen disparities between
bone marrow donor and reeipient are generally not ob-
served in a primary MLR. However, it was recently
shown that putative mH-specific and/or as yet uniden-
tified major Η antigenic T-cell responses can be gener-
ated in vitro without prior in vivo priming by applying
a limiting dilution System [17-19]. Schwarer et al. {18]
and Theobald et al. [19] used IL-2 produetion by re-
sponder cells as an indication of T-cell activation.
By using an alternative approach, we investigated the
capacity of DCs to induce primary proliferative and cy-
totoxic T-cell responses in HLA genotypically identical,
MLR-negative sibling combinations. We found that
DCs were indeed capable of inducing T-ceü proliferation
in these combinations. The superior stimulatory capacity
of DCs was further apparent when simultaneously com-
paring unseparated PBMCs, monocytes, and Β cells as
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TABLE 1 Analyses of DC-induced Τ cell lines from
HLA-identical-sibling combinations
Pair no "
9606
9605
9607-1
9384-1
9560
9540
9384-2
9607-2
9611
9610
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
χ
χ
χ
χ
χ
χ
χ
χ
χ
χ
χ
χ
χ
χ
χ
χ
χ
χ
χ
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
CD4'
depleted
No
No
No
No
No
No
No
No
No
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Protocolr
Standard
Standard
Standard
Standard
Standard
Standard
r-IL7
r-IL7
T-1L7
r-IL7
Standard
Standard
Standard
Standard
r-IL7
r-IL7
Γ-Π.7
r-IL7
r-IL7
CMI/
Auto Spec
-
_ _
_
N C NG
— —
t +
— —
+ V + + + +
+ +
Auto
+
+
+ +
NG
+ + -t
-
_
+
NT*
NT
-
PLT
Spec
+
NG
-
_
Λ
- +V+
NT
NT
-
Phenotype^
%CD4
65
76
58
81
89
93
63
53
35
15
7
79
85
7
10
5
8
16
%CD8
30
20
36
17
8
4
31
44
60
80
89
16
12
91
87
93
90
79
T-cell hnes were generated from cell cultures which were induced with DCs as stimulator cell These
T-cell hnes were expanded according to djfferent culture protocols (see Materials and Metbods)
" Designation for HLA genotypically identical sibling pairs T-cell hnes were generated in two different
directions (a) by Stimulation of Τ cells of individual Α with DCs of mdividual Β (designated as Α Χ Β)
and (b) within the same pair by Stimulation of Τ cells of individual Β with DCs of individual Α
(designated as Β Χ Α)
* The responding T-cell population was depleted or not for C D 4 + cells before the Initiation of the
response with DCs
' Two different protocols were used to generate T-cell hnes. either the Standard protocol or the rlL-7
protocol (see Malenah and Metbods)
J
 T-cell hnes were tested for cytotoxicity in a CML assay Responder cells (auto, autologous cells) and
specific stimulator cells (spec) were used as target cells Cytotoxicity at an effector-tatget ratio of 30 1 was
expressed as % specific lysis - , < 1 0 % lysis, + , 10%-20% lysis, + + , 20%-50% lysis, and + + + ,
> 5 0 % lysis
' T-cell hnes were functionally tested m a Standard PLT Proliferative responses were acpcessed in
Stimulation mdices - , < 4 , + , 4-10; + + , 10-50, and + + + , >50
T-cell hnes wcrc analyzed on a FACScan for the CD8 and CD4 phenotype
* As no growth (NG) was observed, no further analysis was performed
* NT, not tested
stimulator cells (Fig. 3). Even at the highest concentra-
tion of stimulator cells, none of these APCs were capable
of inducing a response between HLA genotypically iden-
tical sibling pairs, whereas the DCs were able to induce
a detectable response at a concentration of 150—500 cells/
well. Α reproducible vanability in the strength of the
primary T-cell response was observed, both within and
between the HLA-identical combinations (Fig. 4). Dis-
crepancies in responsiveness may be caused by differences
in antigenic incompatibilities, either in the absolute
number or in differenüal immunogenicity between the
HLA-identical individuals [20]. Α known property of
DCs to provide a proliferative Stimulus to autologous Τ
cells [3] was observed in three of the five positive
MLDCRs depicted in Fig. 4. The mechanisms underly-
ing this DC characteristic are still not known.
Based on the absence of MLDCRs in the twin pairs
(pair no. 9405 in Fig. 4) and the discrepancy between
allogeneic and autologous MLDCRs in most of the com-
binations, we attempted to isolate mH antigen-specific
Τ cells. Therefore, the MLDCR-positive cultures were
subsequently expanded using two different Stimulation
protocols, which resulted in 19 T-cell lines. It IS clear
from Table 1 that T-cell lines could be generated be-
tween HLA genotypically identical siblings both from
nondepleted purified Τ cells and from CD8 + enriched
T-cell populations. However, none of these DC-induced
T-cell lines discriminated between the autologous and
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the specific stimulator cells (Table 1). Therefore, no as-
sessment can be made of specific reactivity. We were also
unable to detect mH antigen reactivity at the clonal
level.
Despite the fact that we were unable to demonstrate
putative mH antigen-specific reactivities, we show here
two new properties of DCs. First, their capacity to in-
duce in vitro primary T-cell responses between HLA
genotypically identical MLR-negative sibling pairs and,
second, their capacity of inducing autoreactive Τ cells
between HLA genotypically identical siblings.
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